An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

BACKGROUND: Estrogen receptor (ER)-negative breast cancer specimens are predominantly of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and basal subtypes. Although ER-negative disease has overall worse prognosis than does ER-positive breast cancer, not all ER-ne...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Teschendorff, Andrew E, Miremadi, Ahmad, Pinder, Sarah E, Ellis, Ian O, Caldas, Carlos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2007
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374988/
https://ncbi.nlm.nih.gov/pubmed/17683518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gb-2007-8-8-r157
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak